Research and development

We understand that only the most dedicated researchers, world-class facilities, and highest standards in science, quality, and ethics, will deliver the results we need for our patients – and help fulfil more unmet needs. That’s why over the past five years we’ve reinvested 30% of our profits into our facilities and research and development. Our R&D capabilities are recognized worldwide, from pre-clinical research through all phases of clinical development with proven expertise and focus in cancer care.

Pipeline

 

Our growing pipeline includes first-in-class therapies aimed at providing new solutions where no options currently exist, and helping to lift the burden of cancer for patients.

 

LEARN MORE